FDA Demand Labelling Change On Low Testosterone Drugs

New FDA Statement On Testosterone¬†Drugs New Rules on Product Labelling February 28th 2015 Following on from their main announcement back In January 2014, the FDA have updated their statement concerning the labelling of prescription drugs used to treat low testosterone. Following on from new study reports that have identified a potential for health risks, The … Read more


The information in this website is for advice and guidance only. It is based on my own intensive research and personal experiences, and is not intended to replace professional medical advice, or to diagnose or treat any health conditions. All rights reserved.